Help paying for REXULTI® (brexpiprazole)

State Health Insurance Assistance Program (SHIP)

SHIP provides local, in-depth, and unbiased insurance counseling and assistance to Medicare-eligible individuals, their families, and caregivers.

Get a prescription savings card

The REXULTI Savings Card offers two separate benefits for patients with commercial insurance.* Eligible patients may pay as little as $0 for first two months of REXULTI and as little as $5 for refills, including 90-day prescriptions. For generic medication, to which REXULTI has been added, eligible patients may pay as little as $0 per month for up to 12 uses.

Download or print a Savings Card to start saving on your prescription.

Get a card

While costs vary, you can go to REXULTI.com/cost to find out if you are eligible and figure out what your prescription may cost, based on your insurance coverage.

*Terms and Conditions: This Savings Card Program is offered by Otsuka America Pharmaceutical, Inc. and applies to valid REXULTI (brexpiprazole) and/or eligible generic prescriptions. Eligible patients with commercial insurance that have coverage for REXULTI may pay as little as $0 with a maximum benefit of wholesale acquisition cost plus usual and customary pharmacy charges. For eligible generic prescriptions, patients may pay as little as $0 and receive savings up to $100 per 30-day supply.

Limit 1 card per patient. This Savings Card Program is non-transferable, no substitutions are permissible, and this offer is intended solely for the patient’s benefit. Maximum benefits and copay assistance redemption methods may vary as necessary to ensure compliance with these Terms and Conditions. This offer may be used in combination with other point-of-sale savings offers applied automatically at participating pharmacies. Up to 13 uses per calendar year with an annual maximum of $8,180.

Eligibility: Patients must have commercial drug insurance and a prescription consistent with FDA-approved product labeling. Patients are not eligible for this program if their prescription is covered in whole or in part by any state or federal healthcare program, including, but not limited to, Medicare Part D, Medicaid (including Medicaid managed care), Medigap, Veterans Affairs (VA), or Department of Defense (DOD) or TRICARE programs, or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use this Savings Card Program. Only valid in U.S. and Puerto Rico; provided, however, that if generic alternative is or becomes available, residents of Massachusetts and California shall not be eligible to participate in this Savings Card Program. The Savings Card Program is void where prohibited by law, taxed, or restricted. Other conditions may apply. Patients may not seek reimbursement for value received from this Savings Card Program from any third-party payers. Otsuka America Pharmaceutical, Inc. has the right to rescind, revoke, or amend this program at any time without notice. This assistance offer is not health insurance.

Get prescription support with GoodRx

Otsuka has collaborated with GoodRx to give patients and caregivers support on prescription savings during their treatment journey with REXULTI. Head over to GoodRx to find the lowest prices, coupons, and more ways you can save on your REXULTI prescription.

Get started

Learn about patient assistance

If you don’t have health insurance or can’t afford your prescribed Otsuka medication, the Otsuka Patient Assistance Foundation (OPAF) might be able to help you get it at no cost.

OPAF is a nonprofit organization that assists underinsured and uninsured patients and their caregivers who have been prescribed Otsuka medications. There are specific eligibility criteria that applicants must meet prior to their approval for assistance. It’s important to note that Otsuka America Pharmaceutical, Inc. does not control or influence how OPAF distributes funds.

Go to OtsukaPatientAssistance.com to learn more.

For more information, call OPAF at 1-855-727-6274, Monday through Friday, 8 AM to 8 PM eastern time.

Otsuka Patient Support™ Health Information Use and
Disclosure Authorization (“Authorization”)

Permission to Use and Disclose Health Information: This Authorization relates to the Otsuka Patient Experience Program and patient experience team. The Program provides services relating to drugs and devices ("Products") of OPH Inc. and its affiliates and successors ("Otsuka"). Your "Providers," for purposes of this Authorization, include any physician, pharmacy, care center, clinic, or other healthcare facilities and professionals, as well as any discount plan, health plan, or other payors that may have information related to the Products you use. By signing this Authorization, you (or your personal representative on your behalf) allow your Providers and Otsuka, along with the Recipients defined below, to use and disclose some of your Protected Health Information as defined below ("PHI") and as described in this Authorization.

PHI Recipients: Your Providers may give your PHI to Otsuka and any Program operators, manufacturers and distributors of the Product, and contractors ("Recipients"). The Recipients can also re-disclose your information to their contractors, vendors, and third parties that may take over the Program in the future. For example, Otsuka may give your information to vendors, advocacy organizations, patient assistance programs, patient access centers, data aggregators, laboratories, safety program administrators, Otsuka Digital Health, other business partners, website tracking tool vendors, and personnel of these third parties. For purposes of this Authorization, “Recipients” include Otsuka and all of these other third parties. “Recipients” also include any legal representatives, caregivers or other contacts listed in this Authorization.

PHI to be Used and Disclosed: PHI includes any and all health information related to the following:

Your name, address, patient ID number, and other demographic data, date of birth, and information you provide on any forms related to the Products
Healthcare records related to your eligibility for and use of the Products, such as dates of treatment, dosage, and dispensing
The healthcare condition for which the Products were or may be prescribed, or your condition while taking or after stopping the Products. You understand that this may include sensitive PHI
Your experience with the Products, including whether you take them as prescribed
Health coverage, financial, payment, and claim information related to the Product or your ability to pay
Information to help support your transition of care, such as getting discharged from a hospital

Purposes: The Recipients may use, share, and re-disclose your PHI, in electronic or any other form or format, for the following purposes:

Determining if you qualify for and contacting you about the Program and Product-related services
Providing assistance to you regarding the Product, facilitating access to the Product, determining health plan coverage requirements, and communicating with you and the Providers regarding the Product, your treatment, or payment for the Product
Internal data collection, research, and reporting, including reviewing utilization, trends, and future needs of patients and providers
Data analysis including de-identifying the PHI, creating limited data sets, or combining it with other information, and monetizing de-identified data as permitted by law
Establishing your treatment profile, tracking coverage, and determining cost sharing
Examining the effectiveness and operation of the Program
Analysis to help evaluate and improve the Program and create new programs
Consistent with applicable law and any applicable standards of ethical conduct, contacting your healthcare provider(s), law enforcement, emergency services, a family member, or any other person reasonably able to assist if a Recipient has a good faith belief that such action is necessary to prevent or lessen a threat to your health or safety, or to the health and safety of others
Fulfilling the Recipients' legal obligations
Using tracking tools on websites and applications to examine your interaction and experience with Program-related or Product-related platforms and to help the websites and applications function
Proper management and administration of the Recipients and the Program, including re-disclosures to other Recipients, Providers, payors, and service providers as needed to operate the Program

Revocation: You may revoke and cancel this Authorization by calling 1-833-468-7852 emailing [email protected], or sending a written notice to Otsuka Patient Support™, 508 Carnegie Center Drive, Princeton, NJ 08540. If you have questions about the Program, you can talk to your Provider and/or call Otsuka Patient Support™ at that number. If a Provider is disclosing PHI for the Program on an ongoing basis, your revocation will take effect with respect to such Provider when they receive notice of your revocation. Revocation will not affect any uses or disclosures of PHI that took place before such cancellation was received. For example, if your PHI has already been shared with third parties, it will not be able to be deleted. If you revoke this Authorization you will no longer be eligible to receive Program services, but this will not affect your ability to receive the Product.

Voluntary Authorization: You do not have to sign this Authorization. Refusal to sign will not affect the start, continuation, or quality of your treatment or any other treatment, payment, enrollment in health plans, or eligibility for benefits for which you qualify. Your Providers may not condition treatment, payment, enrollment, or eligibility for benefits on whether you sign this Authorization.

Re-Disclosure: Once your PHI is disclosed as allowed in this Authorization, it may be re-disclosed by the Recipients and will no longer be protected by the Health Insurance Portability and Accountability Act (HIPAA). Additionally, it may no longer be protected by certain other state and federal privacy and security laws.

Expiration: This Authorization will remain in effect for one (1) year from the date of the signature(s) below or until it is revoked, whichever is earlier.

Copy of Authorization: You have a right to receive a copy of this authorization.

By signing this Authorization, you acknowledge that you have read and understand this Authorization and expressly authorize the uses and disclosures of PHI referenced in this Authorization.

Consent: By signing this Authorization, I acknowledge and confirm that I have read, understand, and agree to this Authorization and expressly authorize the uses and disclosures of PHI referenced in this Authorization.

Individuals signing electronically: By signing this Authorization electronically, you understand that you will receive a copy of your completed Authorization to the email address that you provide. You must let us know if your email or other contact information changes. You understand that your email system may not be a completely secure form of transmission and is not always encrypted. You understand that you may sign a hard copy of this form if you prefer not to sign electronically.

REXULTI^®

(brexpiprazole) tablets